Logo image of HLBN.DE

HOLCIM LTD (HLBN.DE) Stock Fundamental Analysis

Europe - FRA:HLBN - CH0012214059 - Common Stock

72.08 EUR
+0.82 (+1.15%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

6

HLBN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 13 industry peers in the Construction Materials industry. HLBN scores excellent on profitability, but there are some minor concerns on its financial health. HLBN has a valuation in line with the averages, but it does not seem to be growing. HLBN also has an excellent dividend rating. With these ratings, HLBN could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year HLBN was profitable.
In the past year HLBN had a positive cash flow from operations.
HLBN had positive earnings in each of the past 5 years.
In the past 5 years HLBN always reported a positive cash flow from operatings.
HLBN.DE Yearly Net Income VS EBIT VS OCF VS FCFHLBN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

HLBN has a better Return On Assets (46.72%) than 100.00% of its industry peers.
With an excellent Return On Equity value of 105.31%, HLBN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 10.52%, HLBN belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
HLBN had an Average Return On Invested Capital over the past 3 years of 6.46%. This is in line with the industry average of 8.11%.
The last Return On Invested Capital (10.52%) for HLBN is above the 3 year average (6.46%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 46.72%
ROE 105.31%
ROIC 10.52%
ROA(3y)5.62%
ROA(5y)4.77%
ROE(3y)11.3%
ROE(5y)9.72%
ROIC(3y)6.46%
ROIC(5y)6.04%
HLBN.DE Yearly ROA, ROE, ROICHLBN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

With an excellent Profit Margin value of 71.83%, HLBN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of HLBN has grown nicely.
With an excellent Operating Margin value of 17.33%, HLBN belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
In the last couple of years the Operating Margin of HLBN has grown nicely.
HLBN has a Gross Margin of 44.69%. This is in the lower half of the industry: HLBN underperforms 61.54% of its industry peers.
HLBN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.33%
PM (TTM) 71.83%
GM 44.69%
OM growth 3Y4.25%
OM growth 5Y6.16%
PM growth 3Y9.2%
PM growth 5Y5.79%
GM growth 3Y0.94%
GM growth 5Y0.93%
HLBN.DE Yearly Profit, Operating, Gross MarginsHLBN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so HLBN is creating value.
The number of shares outstanding for HLBN has been reduced compared to 1 year ago.
HLBN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, HLBN has an improved debt to assets ratio.
HLBN.DE Yearly Shares OutstandingHLBN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
HLBN.DE Yearly Total Debt VS Total AssetsHLBN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

An Altman-Z score of 3.74 indicates that HLBN is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.74, HLBN belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
HLBN has a debt to FCF ratio of 2.67. This is a good value and a sign of high solvency as HLBN would need 2.67 years to pay back of all of its debts.
HLBN's Debt to FCF ratio of 2.67 is fine compared to the rest of the industry. HLBN outperforms 76.92% of its industry peers.
HLBN has a Debt/Equity ratio of 0.62. This is a neutral value indicating HLBN is somewhat dependend on debt financing.
HLBN has a Debt to Equity ratio of 0.62. This is amonst the worse of the industry: HLBN underperforms 84.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 2.67
Altman-Z 3.74
ROIC/WACC2.23
WACC4.72%
HLBN.DE Yearly LT Debt VS Equity VS FCFHLBN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

A Current Ratio of 1.49 indicates that HLBN should not have too much problems paying its short term obligations.
HLBN has a Current ratio (1.49) which is comparable to the rest of the industry.
HLBN has a Quick Ratio of 1.21. This is a normal value and indicates that HLBN is financially healthy and should not expect problems in meeting its short term obligations.
HLBN has a Quick ratio (1.21) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.21
HLBN.DE Yearly Current Assets VS Current LiabilitesHLBN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1

3. Growth

3.1 Past

HLBN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 422.14%, which is quite impressive.
HLBN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.24% yearly.
Looking at the last year, HLBN shows a very negative growth in Revenue. The Revenue has decreased by -19.77% in the last year.
Measured over the past years, HLBN shows a decrease in Revenue. The Revenue has been decreasing by -0.24% on average per year.
EPS 1Y (TTM)422.14%
EPS 3Y11.85%
EPS 5Y7.24%
EPS Q2Q%1046.3%
Revenue 1Y (TTM)-19.77%
Revenue growth 3Y-0.53%
Revenue growth 5Y-0.24%
Sales Q2Q%-38.57%

3.2 Future

HLBN is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.57% yearly.
Based on estimates for the next years, HLBN will show a decrease in Revenue. The Revenue will decrease by -6.41% on average per year.
EPS Next Y-37.09%
EPS Next 2Y-18.22%
EPS Next 3Y-9.47%
EPS Next 5Y-5.57%
Revenue Next Year-38.81%
Revenue Next 2Y-20.53%
Revenue Next 3Y-12.93%
Revenue Next 5Y-6.41%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HLBN.DE Yearly Revenue VS EstimatesHLBN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
HLBN.DE Yearly EPS VS EstimatesHLBN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

HLBN is valuated cheaply with a Price/Earnings ratio of 2.42.
Based on the Price/Earnings ratio, HLBN is valued cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.54. HLBN is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 17.12, which indicates a rather expensive current valuation of HLBN.
HLBN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. HLBN is more expensive than 69.23% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.05. HLBN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 2.42
Fwd PE 17.12
HLBN.DE Price Earnings VS Forward Price EarningsHLBN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

61.54% of the companies in the same industry are cheaper than HLBN, based on the Enterprise Value to EBITDA ratio.
61.54% of the companies in the same industry are more expensive than HLBN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.38
EV/EBITDA 8.09
HLBN.DE Per share dataHLBN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

HLBN has an outstanding profitability rating, which may justify a higher PE ratio.
HLBN's earnings are expected to decrease with -9.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.33
EPS Next 2Y-18.22%
EPS Next 3Y-9.47%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.58%, HLBN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.63, HLBN pays a better dividend. On top of this HLBN pays more dividend than 84.62% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, HLBN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.58%

5.2 History

The dividend of HLBN is nicely growing with an annual growth rate of 39.59%!
Dividend Growth(5Y)39.59%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

HLBN pays out 11.12% of its income as dividend. This is a sustainable payout ratio.
DP11.12%
EPS Next 2Y-18.22%
EPS Next 3Y-9.47%
HLBN.DE Yearly Income VS Free CF VS DividendHLBN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B
HLBN.DE Dividend Payout.HLBN.DE Dividend Payout, showing the Payout Ratio.HLBN.DE Dividend Payout.PayoutRetained Earnings

HOLCIM LTD

FRA:HLBN (9/26/2025, 7:00:00 PM)

72.08

+0.82 (+1.15%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)07-31 2025-07-31
Earnings (Next)10-24 2025-10-24
Inst Owners44.14%
Inst Owner ChangeN/A
Ins Owners6.72%
Ins Owner ChangeN/A
Market Cap40.86B
Analysts77.04
Price Target75.8 (5.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.58%
Yearly Dividend3.02
Dividend Growth(5Y)39.59%
DP11.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.88%
PT rev (3m)-28.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)4.79%
EPS NY rev (3m)-42.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-39.99%
Valuation
Industry RankSector Rank
PE 2.42
Fwd PE 17.12
P/S 1.78
P/FCF 10.38
P/OCF 7.6
P/B 2.6
P/tB 5.08
EV/EBITDA 8.09
EPS(TTM)29.82
EY41.37%
EPS(NY)4.21
Fwd EY5.84%
FCF(TTM)6.95
FCFY9.64%
OCF(TTM)9.48
OCFY13.15%
SpS40.58
BVpS27.68
TBVpS14.19
PEG (NY)N/A
PEG (5Y)0.33
Profitability
Industry RankSector Rank
ROA 46.72%
ROE 105.31%
ROCE 13.87%
ROIC 10.52%
ROICexc 12.49%
ROICexgc 18.25%
OM 17.33%
PM (TTM) 71.83%
GM 44.69%
FCFM 17.12%
ROA(3y)5.62%
ROA(5y)4.77%
ROE(3y)11.3%
ROE(5y)9.72%
ROIC(3y)6.46%
ROIC(5y)6.04%
ROICexc(3y)7.58%
ROICexc(5y)7.02%
ROICexgc(3y)13.04%
ROICexgc(5y)11.56%
ROCE(3y)8.52%
ROCE(5y)7.98%
ROICexcg growth 3Y12.63%
ROICexcg growth 5Y13.6%
ROICexc growth 3Y7.66%
ROICexc growth 5Y8.99%
OM growth 3Y4.25%
OM growth 5Y6.16%
PM growth 3Y9.2%
PM growth 5Y5.79%
GM growth 3Y0.94%
GM growth 5Y0.93%
F-Score7
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 2.67
Debt/EBITDA 1.68
Cap/Depr 79.57%
Cap/Sales 6.24%
Interest Coverage 7.36
Cash Conversion 92.82%
Profit Quality 23.83%
Current Ratio 1.49
Quick Ratio 1.21
Altman-Z 3.74
F-Score7
WACC4.72%
ROIC/WACC2.23
Cap/Depr(3y)149.39%
Cap/Depr(5y)143.09%
Cap/Sales(3y)11.07%
Cap/Sales(5y)11.4%
Profit Quality(3y)72.22%
Profit Quality(5y)84.38%
High Growth Momentum
Growth
EPS 1Y (TTM)422.14%
EPS 3Y11.85%
EPS 5Y7.24%
EPS Q2Q%1046.3%
EPS Next Y-37.09%
EPS Next 2Y-18.22%
EPS Next 3Y-9.47%
EPS Next 5Y-5.57%
Revenue 1Y (TTM)-19.77%
Revenue growth 3Y-0.53%
Revenue growth 5Y-0.24%
Sales Q2Q%-38.57%
Revenue Next Year-38.81%
Revenue Next 2Y-20.53%
Revenue Next 3Y-12.93%
Revenue Next 5Y-6.41%
EBIT growth 1Y-15.09%
EBIT growth 3Y3.69%
EBIT growth 5Y5.91%
EBIT Next Year-19.04%
EBIT Next 3Y-2.93%
EBIT Next 5Y0.89%
FCF growth 1Y835.12%
FCF growth 3Y238.03%
FCF growth 5Y4.99%
OCF growth 1Y15.53%
OCF growth 3Y3.95%
OCF growth 5Y3.27%